Ajanta Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE031B01049
  • NSEID: AJANTPHARM
  • BSEID: 532331
INR
3,515.65
5.8 (0.17%)
BSENSE

Aug 11

BSE+NSE Vol: 9.47 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 178818,
    "name": "Ajanta Pharma",
    "stock_name": "Ajanta Pharma",
    "full_name": "Ajanta Pharma Ltd.",
    "name_url": "stocks-analysis/ajanta-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "3,515.65",
    "chg": 5.8,
    "chgp": "0.17%",
    "dir": 1,
    "prev_price": "3,509.85",
    "mcapval": "43,931.22 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532331,
    "symbol": "AJANTPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE031B01049",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "9.47 k",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/ajanta-pharma-178818-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Ajanta Pharma Ltd soars 0.37%, rises for fifth straight session",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-08-04 13:17:05",
        "description": "Ajanta Pharma Ltd soars 0.37%, rises for fifth straight session  Business Standard..."
      },
      {
        "title": "Ajanta Pharma Q1 result: PAT rises 31% to 334 cr on strong India, US sales",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-30 15:30:21",
        "description": "Ajanta Pharma Q1 result: PAT rises 31% to 334 cr on strong India, US sales  Business Standard..."
      },
      {
        "title": "Ajanta Pharma Q1 results: PAT rises 31% to 334 cr",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-30 15:06:47",
        "description": "Ajanta Pharma Q1 results: PAT rises 31% to 334 cr  BusinessLine..."
      },
      {
        "title": "Trump\\'s tariff policy: Abbott India, Ajanta Pharma to Alembic  pharma stocks crash up to 4%",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-24 11:01:00",
        "description": "Trump\\'s tariff policy: Abbott India, Ajanta Pharma to Alembic  pharma stocks crash up to 4%  livemint.com..."
      },
      {
        "title": "Cipla, Ajanta Pharma to Alkem Laboratories: Pharma stocks rise amid weak trends on Dalal Street",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-20 12:38:08",
        "description": "Cipla, Ajanta Pharma to Alkem Laboratories: Pharma stocks rise amid weak trends on Dalal Street  livemint.com..."
      },
      {
        "title": "Ajanta Pharma Ltd gains for third consecutive session",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-13 13:17:57",
        "description": "Ajanta Pharma Ltd gains for third consecutive session  Business Standard..."
      }
    ],
    "total": 6,
    "sid": "178818",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/ajanta-pharma-178818"
  },
  "announcements": [
    {
      "caption": "Participation In Investor Conference",
      "datetime": "05-Aug-2026",
      "details": "Pls find enclosed Intimation w.r.t participation in Investor Conference",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "03-Aug-2026",
      "details": "Pls find enclosed herewith Earning Call Transcript",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "31-Jul-2026",
      "details": "Pls find enclosed newspaper publication of financial results for the quarter ended 30.06.2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has declared <strong>1600%</strong> dividend, ex-date: 05 Aug 26",
          "dt": "2026-08-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has announced <strong>2:5</strong> stock split, ex-date: 20 Mar 15",
          "dt": "2015-03-20",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has announced <strong>1:2</strong> bonus issue, ex-date: 22 Jun 22",
          "dt": "2022-06-22",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Participation In Investor Conference

05-Aug-2026 | Source : BSE

Pls find enclosed Intimation w.r.t participation in Investor Conference

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

03-Aug-2026 | Source : BSE

Pls find enclosed herewith Earning Call Transcript

Announcement under Regulation 30 (LODR)-Newspaper Publication

31-Jul-2026 | Source : BSE

Pls find enclosed newspaper publication of financial results for the quarter ended 30.06.2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Ajanta Pharma Ltd. has declared 1600% dividend, ex-date: 05 Aug 26

stock-summary
SPLITS

Ajanta Pharma Ltd. has announced 2:5 stock split, ex-date: 20 Mar 15

stock-summary
BONUS

Ajanta Pharma Ltd. has announced 1:2 bonus issue, ex-date: 22 Jun 22

stock-summary
RIGHTS

No Rights history available